相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response
Luca Azzolin et al.
CELL (2014)
Inactivation of Wnt Signaling by a Human Antibody That Recognizes the Heparan Sulfate Chains of Glypican-3 for Liver Cancer Therapy
Wei Gao et al.
HEPATOLOGY (2014)
Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling
Mariana Capurro et al.
JOURNAL OF CELL SCIENCE (2014)
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
Ronit Mazor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update
Angela Gauthier et al.
HEPATOLOGY RESEARCH (2013)
Novel Immunocytokine IL12-SS1 (Fv) Inhibits Mesothelioma Tumor Growth in Nude Mice
Heungnam Kim et al.
PLOS ONE (2013)
Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma
Mingqian Feng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Major Cancer Regressions in Mesothelioma After Treatment with an Anti-Mesothelin Immunotoxin and Immune Suppression
Raffit Hassan et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
TEM8/ANTXR1 Blockade Inhibits Pathological Angiogenesis and Potentiates Tumoricidal Responses against Multiple Cancer Types
Amit Chaudhary et al.
CANCER CELL (2012)
Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma - A phase II trial of the childhood liver tumour strategy group (SIOPEL)
Jozsef Zsiros et al.
EUROPEAN JOURNAL OF CANCER (2012)
Simultaneous inhibition of Src and Aurora kinases by SU6656 induces therapeutic synergy in human synovial sarcoma growth, invasion and angiogenesis in vivo
Ryuta Arai et al.
EUROPEAN JOURNAL OF CANCER (2012)
Wnt/β-Catenin Signaling Regulates Yes-associated Protein (YAP) Gene Expression in Colorectal Carcinoma Cells
Wesley M. Konsavage et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening
Yen Phung et al.
MABS (2012)
Advances in Liver Cancer Antibody Therapies A Focus on Glypican-3 and Mesothelin
Mitchell Ho
BIODRUGS (2011)
Antibody Fusion Proteins: Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox
Robert J. Kreitman et al.
CLINICAL CANCER RESEARCH (2011)
Glypican-3: A new target for cancer immunotherapy
Mitchell Ho et al.
EUROPEAN JOURNAL OF CANCER (2011)
A novel high-affinity human monoclonal antibody to mesothelin
Mitchell Ho et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Recombinant soluble glypican 3 protein inhibits the growth of hepatocellular carcinoma in vitro
Mingqian Feng et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells
Kuen-Feng Chen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2010)
Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells
Kiyotaka Nakano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Enhancing the Antitumor Activity of Adriamycin and Ionizing Radiation
Wenqing Sun et al.
CANCER RESEARCH (2009)
Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma
Hirofumi Shirakawa et al.
CANCER SCIENCE (2009)
Anti-Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer
Takahiro Ishiguro et al.
CANCER RESEARCH (2008)
Differential cellular internalization of anti-CD19 and-CD22 immunotoxins results in different cytotoxic activity
Xing Du et al.
CANCER RESEARCH (2008)
ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft
Viraj J. Jasinghe et al.
JOURNAL OF HEPATOLOGY (2008)
Construction of a large phage-displayed human antibody domain library with a scaffold based on a newly identified highly soluble, stable heavy chain variable domain
Weizao Chen et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Immunotoxin treatment of cancer
Ira Pastan et al.
ANNUAL REVIEW OF MEDICINE (2007)
Tumor models for efficacy determination
Beverly A. Teicher
MOLECULAR CANCER THERAPEUTICS (2006)
Synergistic antitumor activity of taxol and immunotoxin SS1P in tumor-bearing mice
YuJian Zhang et al.
CLINICAL CANCER RESEARCH (2006)
Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma:: A multicenter phase II study with dose adjustment according to baseline serum bilirubin level
V Boige et al.
EUROPEAN JOURNAL OF CANCER (2006)
Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling
MI Capurro et al.
CANCER RESEARCH (2005)
In vitro antibody evolution targeting germline hot spots to increase activity of an anti-CD22 immunotoxin
M Ho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages
MC Bibby
EUROPEAN JOURNAL OF CANCER (2004)
Glypican-3 is involved in cellular protection against mitoxantrone in gastric carcinoma cells
A Wichert et al.
ONCOGENE (2004)
Primary liver cancer:: Worldwide incidence and trends
FX Bosch et al.
GASTROENTEROLOGY (2004)
Processing by proprotein convertases is required for glypican-3 modulation of cell survival, Wnt signaling, and gastrulation movements
B De Cat et al.
JOURNAL OF CELL BIOLOGY (2003)
分享论文
